While the battle for Allergan was played out very publicly in the press over the period of a year, gaining the perspective of an insider to the transaction is a rare opportunity.
Latham & Watkins, the law firm which represented Allergan, hosted a webinar to give us that insider’s perspective. Several Latham attorneys directly involved in the transaction and Arnold Pinkston, the former General Counsel of Allergan each provide valuable insights about the specific transaction as well as more general recommendations for public companies.
Click here to register for the webinar on demand (registration required).
Excerpt about the webinar.
This 60-minute webcast is an opportunity to hear from Allergan’s former General Counsel, about the company’s experience with a hostile acquisition bid by Valeant and subsequent sale to another bidder.
The Latham lawyers who helped guide Allergan in responding to the bid – which was partially funded by activist hedge fund Pershing Square – will also discuss lessons learned.
With a focus on best practices drawn from Allergan’s experience implementing and utilizing takeover and activism defense plans, participants will come away with an understanding of the practical steps that can be taken well in advance of unsolicited offers, in order to achieve a position of strength before an acquirer comes knocking at the door.